Mayne Pharma (ASX:MYX) sells Metrics Contract Services for US$475m
Mayne Pharma (MYX) is selling its long time subsidiary Metrics Contract Services…
Mayne Pharma Group Limited (ASX:MYX)
About Mayne Pharma Group Limited
Key Information
MYX In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 10/08/2022 | Ceasing to be a substantial holder | 200.15KB | 2.6K |
| 10/08/2022 | Price Sensitive PS Mayne Pharma announces sale of Metrics Contract Services | 189.91KB | 23K |
| 08/08/2022 | FDA approval of HALOETTE, a generic version of NUVARING | 214.84KB | 6.4K |
| 02/08/2022 | Change of Director's Interest Notice | 258.05KB | 325 |
| 02/08/2022 | Notification of cessation of securities - MYX | 21.69KB | 179 |
| 02/08/2022 | NEXTSTELLIS nominated for 2022 Prix Galien USA Award | 182.5KB | 1.4K |
| 02/08/2022 | Update - Notification of buy-back - MYX | 24.12KB | 273 |
| 29/07/2022 | MYX and GoodRx announce NEXTSTELLIS DTC campaign | 247.79KB | 1.8K |